APA (7th ed.) Citation

P, M., F, V., M, P., R, B., L, M., JS, N., . . . JP, F. (2026). Polycythemia, SGLT2 inhibitors, and associated outcomes across the cardio-kidney-metabolic spectrum: A pooled analysis of randomized trials. European journal of internal medicine, 106989. https://doi.org/10.1016/j.ejim.2026.106989

Chicago Style (17th ed.) Citation

P, Marques, et al. "Polycythemia, SGLT2 Inhibitors, and Associated Outcomes Across the Cardio-kidney-metabolic Spectrum: A Pooled Analysis of Randomized Trials." European Journal of Internal Medicine 2026: 106989. https://doi.org/10.1016/j.ejim.2026.106989.

MLA (9th ed.) Citation

P, Marques, et al. "Polycythemia, SGLT2 Inhibitors, and Associated Outcomes Across the Cardio-kidney-metabolic Spectrum: A Pooled Analysis of Randomized Trials." European Journal of Internal Medicine, 2026, p. 106989, https://doi.org/10.1016/j.ejim.2026.106989.